ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,509.01
0.62%
US Tech 100
19,479.20
0.00%
Dow Jones
39,331.85
0.41%
Brent Oil
86.465
0.02%
Bitcoin
60,787.70
-2.00%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. BioPharmX Corporation (BPMX)

  7. BioPharmX Corporation (BPMX) News

BPMX

BioPharmX (BPMX)

BioPharmX Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:BPMX
DateTimeSourceHeadlineSymbolCompany
03/16/20179:15AMPR Newswire (US)BioPharmX to Report Fourth Quarter and Full Year Financial ResultsAMEX:BPMXBioPharmX Corporation
03/13/20179:15AMPR Newswire (US)BioPharmX Society of Toxicology Poster Suggests Promise of BPX-01 as Topical Acne Therapy, Highlights SafetyAMEX:BPMXBioPharmX Corporation
03/09/20179:15AMPR Newswire (US)BioPharmX to Present at 29th Annual ROTH ConferenceAMEX:BPMXBioPharmX Corporation
03/02/20179:15AMPR Newswire (US)BioPharmX Presents Poster at American Academy of Dermatology Annual Meeting Suggesting BPX-01 Safely, Efficiently Delivers Ac...AMEX:BPMXBioPharmX Corporation
02/22/20174:22PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BPMXBioPharmX Corporation
02/21/20174:18PMEdgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:BPMXBioPharmX Corporation
02/21/20174:08PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
02/13/20175:32PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
02/10/20175:12PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BPMXBioPharmX Corporation
01/31/20171:26PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
01/26/20179:15AMPR Newswire (US)SPIE Photonics West Presentations to Show BioPharmX was First to Visualize Minocycline on the Skin Using Multiphoton Microsco...AMEX:BPMXBioPharmX Corporation
01/23/20174:32PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
01/23/20179:15AMPR Newswire (US)Specialty Pharma Industry Veteran Charles Gregory Vontz Joins BioPharmX Board of DirectorsAMEX:BPMXBioPharmX Corporation
01/20/20176:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
01/20/20176:02PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
01/12/20179:15AMPR Newswire (US)BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline GelAMEX:BPMXBioPharmX Corporation
01/04/20179:15AMPR Newswire (US)BioPharmX Completes Enrollment of BPX-01 Phase 2b OPAL Clinical Trial for Acne VulgarisAMEX:BPMXBioPharmX Corporation
12/19/20164:14PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
12/13/20164:40PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
12/13/20164:16PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
12/13/20164:05PMPR Newswire (US)BioPharmX Corporation Reports Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
12/12/20165:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
12/12/20165:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
12/12/20165:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
12/12/20165:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
12/12/20165:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
12/07/20169:00AMPR Newswire (US)BioPharmX to present evidence that BPX-01 topical minocycline gel may reduce acne-associated inflammationAMEX:BPMXBioPharmX Corporation
12/06/20168:00AMPR Newswire (US)BioPharmX to Report Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
12/05/20169:00AMPR Newswire (US)BioPharmX Presents Research at Cell Biology 2016 Showing How Molecular Iodine Promotes Breast Health by Attacking Fibrocystic...AMEX:BPMXBioPharmX Corporation
12/02/20162:38PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
 Showing the most relevant articles for your search:AMEX:BPMX

Your Recent History

USOTC
NNAX
New Momentum (PK)
NASDAQ
TSLA
Tesla
USOTC
ASKH
Astika (PK)
USOTC
CNNA
Cann American (CE)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
PHIL
PHI (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
HMBL
HUMBL (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
AXXA
Exxe (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
RXMD
Progressive Care (QB)
USOTC
GGSM
Gold and GemStone Mining (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved